HC Wainwright Maintains Buy Rating on Voyager Therapeutics with $25 PT.

miércoles, 12 de noviembre de 2025, 1:46 pm ET1 min de lectura
VYGR--

HC Wainwright Maintains Buy Rating on Voyager Therapeutics with $25 PT.

HC Wainwright Maintains Buy Rating on Voyager Therapeutics with $25 PT.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios